| Pharmaceutical active ingredients: |
| Paraoxon |
| Available forms, composition and doses of Miotisal: |
| N / A |
| Miotisal medical category: |
| Human:Acetylcholinesterase inhibitorsParasympathomimetics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| S01EB10 - Paraoxon |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mioril | Carisoprodol | Unidentified Pharmaceutical Company |
| Miorilas | Methocarbamol | Unidentified Pharmaceutical Company |
| Miorilax | Chlormezanone | Unidentified Pharmaceutical Company |
| Mioriodol | Carisoprodol | Unidentified Pharmaceutical Company |
| Mio-Sed | Chlormezanone | Unidentified Pharmaceutical Company |
| Miotisal A | Paraoxon | Unidentified Pharmaceutical Company |
| Miotran | Chlorzoxazone | Unidentified Pharmaceutical Company |
| Mipax | Dimethylphthalate | Unidentified Pharmaceutical Company |
| Miramel | Methylpentynol | Unidentified Pharmaceutical Company |
| Mirataine CB | Cocamidopropyl Betaine | Unidentified Pharmaceutical Company |